Countering the classical renin-angiotensin system

被引：1
作者：
Noto, Natalia M. [1 ]
Restrepo, Yazmin M. [1 ]
Speth, Robert C. [1 ]
机构：
[1] Nova Southeastern Univ, Coll Pharm, Ft Lauderdale, FL 33328 USA
来源：
CLINICAL SCIENCE | 2021年 / 135卷 / 23期
关键词：
BLOOD-PRESSURE; ACE2; OVEREXPRESSION; HYPERTENSION; EXPRESSION; PEPTIDE;
D O I：
10.1042/CS20211043
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
It is well-established that Ang-(1-7) counteracts the effects of Ang II in the periphery, while stimulating vasopressin release and mimicking the activity of Ang II in the brain, through interactions with various receptors. The rapid metabolic inactivation of Ang-(1-7) has proven to be a limitation to therapeutic administration of the peptide. To circumvent this problem, Alves et al. (Clinical Science (2021) 135(18), https://doi.org/10.1042/CS20210599) developed a new transgenic rat model that overexpresses an Ang-(1-7)-producing fusion protein. In this commentary, we discuss potential concerns with this model while also highlighting advances that can ensue from this significant technical feat.
引用
收藏
页码：2619 / 2623
页数：5
相关论文
共 50 条
  • [41] Genetic variation in the renin-angiotensin system, use of renin-angiotensin system inhibitors and the risk of myocardial infarction
    Maitland-van der Zee, Anke-Hilse
    van Wieren-de Wijer, Diane B. M. A.
    de Boer, Anthonius
    Kroon, Abraham A.
    de Leeuw, Peter W.
    Schiffers, Paul
    Janssen, Rob G. J. H.
    Psaty, Bruce M.
    van Duijn, Cornelia M.
    Stricker, Bruno H. Ch
    Klungel, Olaf H.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2011, 12 (03) : 208 - 214
  • [42] Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension
    Doulton, Timothy W. R.
    MacGregor, Graham A.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2009, 10 (04) : 185 - 189
  • [43] The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease
    Goto, Miwa
    Hoxha, Nita
    Osman, Rania
    Dell, Katherine MacRae
    PEDIATRIC NEPHROLOGY, 2010, 25 (12) : 2449 - 2457
  • [44] Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
    Labandeira-Garcia, Jose L.
    Labandeira, Carmen M.
    Valenzuela, Rita
    Pedrosa, Maria A.
    Quijano, Aloia
    Rodriguez-Perez, Ana I.
    BIOMEDICINES, 2022, 10 (02)
  • [45] Importance of the (Pro)renin Receptor in Activating the Renin-Angiotensin System During Normotensive and Preeclamptic Pregnancies
    Schofield, Lachlan G.
    Endacott, Saije K.
    Delforce, Sarah J.
    Lumbers, Eugenie R.
    Pringle, Kirsty G.
    CURRENT HYPERTENSION REPORTS, 2024, 26 (12) : 483 - 495
  • [46] Involvement of the renin-angiotensin system in migraine
    Tronvik, Erling
    Stovner, Lars J.
    Schrader, Harald
    Bovim, Gunnar
    JOURNAL OF HYPERTENSION, 2006, 24 : S139 - S143
  • [47] Renin-Angiotensin System Blocking Drugs
    Roberto Robles, Nicolas
    Cerezo, Isis
    Hernandez-Gallego, Roman
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (01) : 14 - 33
  • [48] Intratubular Renin-Angiotensin System in Hypertension
    Navar, L. Gabriel
    Kobori, Hiroyuki
    Prieto, Minolfa C.
    Gonzalez-Villalobos, Romer A.
    HYPERTENSION, 2011, 57 (03) : 355 - 362
  • [49] The “His and Hers” of the Renin-Angiotensin System
    Lucinda M. Hilliard
    Amanda K. Sampson
    Russell D. Brown
    Kate M. Denton
    Current Hypertension Reports, 2013, 15 : 71 - 79
  • [50] Is the renin-angiotensin system actually hypertensive?
    Berard, Etienne
    Niel, Olivier
    Rubio, Amandine
    PEDIATRIC NEPHROLOGY, 2014, 29 (06) : 951 - 960
12345